NASDAQ: LUCD - Lucid Diagnostics Inc.

Yield per half year: +1.03%
Sector: Healthcare

Lucid Diagnostics Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -4.23 -100%
P/S 24.08 33.76 -28.68%
P/BV -25.3 4.82 -624.73%
P/FCF 0 61 -100%
Ev/Ebitda -1.19 -22.15 -94.62%
Ev/S 22.58 22.56 0.0587%
Ev/FCF -1.66 68.78 -102.41%
E/P 0 0.0178 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-1893.86 4.98 -38152.77% -7306 -74.08%
ROE 2278.93 9.61 23610.21%
ROA -193.13 0.3443 -56199.54%
ROIC 0 7.63 -100%
ROS -2169.11 -25.17 8517.8%
ROCE 2097.88 15.35 13566.67%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.3318 -3.68 -90.97% -0.2517 +31.78%
Nеt Debt/Ebitda 0.0792 -3.44 -102.3%
Debt/Ratio 0.5594 0.1985 181.84%
Debt/Equity 9.53 1.66 473.59%
Debt/Net Income -0.2897 10.32 -102.81%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5442 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2237 -100%
Average dividend growth 0 0.9889 -100%
Average percentage for 5 years 0 0.4952 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5442

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
385.6 -56.89 -777.8%
Growth impulse Ebitda in 5 years 1030.7 -54.68 -1984.97%
Growth impulse Net Income in 5 years 1096.95 -58.33 -1980.59%
Growth impulse FCF in 5 years 1276.58 -49.48 -2679.99%
Growth impulse EPS in 5 years 955.46 -32.41 -3048.04%
IP Score
4.9/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription